The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases
Open accessAbstract
PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“only BSC is recommended, as their median survival is <2 months.”
From Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (2016) · cites this paper as [148]
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citationSperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citationAn Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citationIntracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citationSperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Therneau TM, 1997, Technical Report 61
Cited by
Sorted by citations
Items 401–500 of 1,000
Quigley, M. R., Bello, N. R., Jho, D. H., Fuhrer, R., Karlovits, S., & Buchinsky, F. J. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000707 · Cited by 26
Lin, J., Lin, D., Xu, L., Wang, Q., Hu, H., Xu, H., & He, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.13787 · Cited by 26
Inno, A., Noia, V. D., D’Argento, E., Modena, A., & Gori, S. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.11.01 · Cited by 26
Shi, Y., Sun, Y. P., Yu, J., Ding, C., Ma, Z., Wang, Z., Wang, D., Wang, Z., Wang, M., Wang, Y., et al. (2017) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2017.01.01 · Cited by 26
Ramos, A. A., Sanchez, C., Fernandez, V., & Vega, M. A. Á. (2017) · Journal of Neurological Surgery Part A Central European Neurosurgery · doi:10.1055/s-0037-1601874 · Cited by 26
Shroff, G. S., Viswanathan, C., Carter, B. W., Benveniste, M. F. K., Truong, M. T., & Sabloff, B. S. (2018) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2018.01.009 · Cited by 26
Soike, M. H., McTyre, E., Hughes, R. T., Farris, M. K., Cramer, C. K., LeCompte, M. C., Lanier, C. M., Ruiz, J., Su, J., Watabe, K., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2888-3 · Cited by 26
Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications
Hadjipanteli, A., Doolan, P., Kyriacou, E. C., & Constantinidou, A. (2020) · Cancer Management and Research · doi:10.2147/cmar.s252801 · Cited by 26
Nieder, C., Andratschke, N. H., Geinitz, H., & Grosu, A. (2012) · Strahlentherapie und Onkologie · doi:10.1007/s00066-012-0107-2 · Cited by 26
Integration of immuno-oncology with stereotactic radiosurgery in the management of brain metastases
Lehrer, E. J., McGee, H. M., Sheehan, J. P., & Trifiletti, D. M. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03427-6 · Cited by 25
Prognostic factors of colorectal cancer patients with brain metastases
Roussille, P., Auvray, M., Vansteene, D., Lecomte, T., Rigault, E., Maillet, M., Locher, C., Dior, M., Hautefeuille, V., Artru, P., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.02.006 · Cited by 25
Palliative Radiotherapy for Advanced Cancers
Williams, G. R., Manjunath, S. H., Butala, A. A., & Jones, J. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.02.007 · Cited by 25
Kim, G. J., Buckley, E. D., Herndon, J. E., Allen, K. J., Dale, T. S., Adamson, J. D., Lay, L. M., Giles, W. M., Rodrigues, A., Wang, Z., et al. (2021) · Advances in Radiation Oncology · doi:10.1016/j.adro.2021.100760 · Cited by 25
Self-citationBadrigilan, S., Meola, A., Chang, S. D., Rezaeian, S., Nemati, H., Almasi, T., & Rostampour, N. (2022) · British Journal of Neurosurgery · doi:10.1080/02688697.2021.2022098 · Cited by 25
Assessment of prognostic scores in brain metastases from breast cancer
Tabouret, É., Métellus, P., Gonçalvès, A., Esterni, B., Charafe‐Jauffret, E., Viens, P., & Tallet, A. R. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not200 · Cited by 25
Ahn, H. K., Lee, S. H., Park, Y. H., Sohn, J., Jo, J., Ahn, J., Jung, K. H., Park, S., Cho, E. Y., Lee, J. I., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos137 · Cited by 25
Radiothérapie des métastases cérébrales
Latorzeff, I., Antoni, D., Gaudaire‐Josset, S., Feuvret, L., Tallet, A. R., Truc, G., & Noël, G. (2016) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2016.07.041 · Cited by 25
Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer
Churilla, T. M., & Weiss, S. E. (2018) · Current Oncology Reports · doi:10.1007/s11912-018-0695-9 · Cited by 26
Immune checkpoint inhibitors and radiosurgery for newly diagnosed melanoma brain metastases
Robin, T. P., Breeze, R. E., Smith, D. E., Rusthoven, C. G., Lewis, K. D., Gonzalez, R. C., Brill, A., Saiki, R., Stuhr, K. A., Gaspar, L. E., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2930-5 · Cited by 25
Self-citationKim, I. A., Lee, J. S., Kim, H. J., Kim, W. S., & Lee, K. Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-4691-0 · Cited by 25
Defining the radiation oncologist’s role in palliative care and radiotherapy
Lam, T. C., & Tseng, Y. D. (2018) · Annals of Palliative Medicine · doi:10.21037/apm.2018.10.02 · Cited by 25
Dover, L. L., Dulaney, C. R., Williams, C., Fiveash, J. B., Jackson, B. E., Warren, P. P., Kvale, E. A., Boggs, D. H., & Rocque, G. B. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox220 · Cited by 24
Self-citationThe Role of Stereotactic Biopsy in Brain Metastases
Yu, K. K. H., Patel, A., & Moss, N. S. (2020) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2020.06.002 · Cited by 26
Dicpinigaitis, A. J., Hanft, S. J., Cooper, J., Gandhi, C. D., Kazim, S. F., Schmidt, M. H., Al‐Mufti, F., & Bowers, C. A. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10138-3 · Cited by 24
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases
Hasanov, M., Milton, D. R., Davies, A. B., Sirmans, E., Saberian, C., Posada, E. L., Opusunju, S., Gershenwald, J. E., Torres-Cabala, C. A., Burton, E. M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac251 · Cited by 24
Hu, X., Zhang, S., Ma, Z., Feng, J., Wu, L., Lv, D., Zhou, J., Zhang, X., Liu, L., Yu, Q., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02865-z · Cited by 26
Wang, T., Chao, H., Chiu, H., Lu, C., Liao, C.-Y., Lee, Y., Chen, J.-R., Shiao, T., Chen, Y., & Wu, Y. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101826 · Cited by 24
Validity of Prognostic Grading Indices for Brain Metastasis Patients Undergoing Repeat Radiosurgery
Yamamoto, M., Kawabe, T., Higuchi, Y., Sato, Y., Nariai, T., Watanabe, S., Barfod, B. E., & Kasuya, H. (2014) · World Neurosurgery · doi:10.1016/j.wneu.2014.08.008 · Cited by 24
Kuba, S., Ishida, M., Nakamura, Y., Yamanouchi, K., Minami, S., Taguchi, K., Eguchi, S., & Ohno, S. (2014) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyu126 · Cited by 24
Nieder, C., Norum, J., Dalhaug, A., Aandahl, G., & Engljähringer, K. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-1840-5 · Cited by 24
Marcus, L. P., Marshall, D. C., Hirshman, B. R., McCutcheon, B. A., Gonda, D. D., Koiso, T., Hattangadi-Gluth, J. A., Carter, B. S., Yamamoto, M., & Chen, C. C. (2015) · Neurosurgery · doi:10.1227/neu.0000000000001123 · Cited by 24
Shen, C. J., Lim, M. K., & Kleinberg, L. R. (2016) · Current Treatment Options in Oncology · doi:10.1007/s11864-016-0423-3 · Cited by 24
Cancer and the metastatic substrate
Arvelo, F. A., Sojo, F. J., & Cotte, C. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.701 · Cited by 25
Trino, E., Mantovani, C., Badellino, S., Ricardi, U., & Filippi, A. R. (2017) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2017.1296764 · Cited by 24
Fernandes, A. W., Wu, B., & Turner, R. M. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1361960 · Cited by 24
Agarwal, J. P., Chakraborty, S., Laskar, S. G., Mummudi, N. B., Patil, V. M., Prabhash, K., Noronha, V., Purandare, N. C., Joshi, A., Tandon, S., et al. (2017) · ecancermedicalscience · doi:10.3332/ecancer.2017.779 · Cited by 24
Liu, Y., Deng, L., Zhou, X., Gong, Y., Xu, Y., Zhou, L., Wan, J., Zou, B., Wang, Y., Zhu, J., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.22785 · Cited by 24
Global DNA demethylation as an epigenetic marker of human brain metastases
Barciszewska, A. (2018) · Bioscience Reports · doi:10.1042/bsr20180731 · Cited by 24
Steindl, A., Schlieter, F., Klikovits, T., Leber, E., Gatterbauer, B., Frischer, J. M., Dieckmann, K. U., Widhalm, G., Zöchbauer‐Müller, S., Hoda, M. A. R., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03269-x · Cited by 25
Chang, C.-H., Lee, C., Ko, J., Chang, L., Lee, M., Zhang, J.-F., Wang, J., Shih, J., & Yu, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.583529 · Cited by 24
Tang, L., Zhang, W., & Chen, L. (2024) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s460856 · Cited by 23
Karam, I., Hamilton, S. N., Nichol, A., Woods, R. R., Speers, C. H., Kennecke, H. F., & Tyldesley, S. K. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-12 · Cited by 23
Janni, W., Schneeweiß, A., Müller, V., Wöckel, A., Lux, M. P., Hartkopf, A. D., Nabieva, N., Taran, F., Tesch, H., Overkamp, F., et al. (2019) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0842-6661 · Cited by 23
Lu, F., Hou, Y., Xia, Y., Li, L., Wang, L., Cao, K., Chen, H., Li, C., & Li, W. (2019) · Cancer Management and Research · doi:10.2147/cmar.s203461 · Cited by 23
Kim, Y. I., Shin, J. Y., Yang, S.-H., Kim, H., Shim, B. Y., & Ahn, S. (2022) · Current Oncology · doi:10.3390/curroncol29090508 · Cited by 23
Layer, J. P., Shiban, E., Brehmer, S., Diehl, C., de Castro, D. G., Hamed, M., Dejonckheere, C. S., Cifarelli, D. T., Friker, L. L., Herrlinger, U., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2024.01.009 · Cited by 23
Qin, H., Pan, F., Li, J., Zhang, X., Liang, H., & Ruan, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111475 · Cited by 23
Liu, M., Cortés, J., & O’Shaughnessy, J. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9619-z · Cited by 23
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Chacón, J. I., de la Cruz‐Merino, L., Gregori, J. G., de Dueñas, E. M., Oliveira, M., Seguí, M. Á., Álvarez, I., Antolín, S., Bellet, M., & López‐Tarruella, S. (2019) · Clinical & Translational Oncology · doi:10.1007/s12094-018-02010-w · Cited by 24
Eljalby, M., Pannullo, S. C., Schwartz, T. H., Parashar, B., & Wernicke, A. G. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.04.093 · Cited by 23
Schimmel, W. C. M., Gehring, K., Hanssens, P. E. J., & Sitskoorn, M. M. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03292-y · Cited by 23
Overcoming the blood–brain barrier by Annexin A1-binding peptide to target brain tumours
Nonaka, M., Suzuki‐Anekoji, M., Nakayama, J., Mabashi‐Asazuma, H., Jarvis, D. L., Yeh, J.-C., Yamasaki, K., Akama, T. O., Huang, C., Campos, A. R., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01066-2 · Cited by 23
Fang, L., Zhao, W., Ye, B., & Chen, D. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.670313 · Cited by 23
Radiation therapy for brain metastases
Latorzeff, I., Antoni, D., Josset, S., Noël, G., & Tallet, A. R. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.11.010 · Cited by 23
Surgery on motor area metastasis
Rossetto, M., Ciccarino, P., Lombardi, G., Rolma, G., Cecchin, D., & Puppa, A. D. (2015) · Neurosurgical Review · doi:10.1007/s10143-015-0648-9 · Cited by 23
Rusthoven, C. G., Camidge, D. R., Robin, T. P., & Brown, P. D. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01823 · Cited by 23
Self-citationRenaud, S., Schaeffer, M., Voegeli, A., Legrain, M., Guérin, É., Meyer, N., Mennecier, B., Quoix, É., Falcoz, P., Guénot, D., et al. (2015) · Future Oncology · doi:10.2217/fon.15.273 · Cited by 22
Brain Metastasis: Clinical Implications of Branched Evolution
Dagogo‐Jack, I., Carter, S. L., & Brastianos, P. K. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.06.005 · Cited by 23
Factors that determine local control with gamma knife radiosurgery: The role of primary histology.
Black, P. J., Page, B. R., Lucas, J. T., Hughes, R. T., Laxton, A., Tatter, S. B., Munley, M., & Chan, M. D. (2015) · Europe PMC (PubMed Central) · Cited by 22
Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
Ma, K., & Hu, P. (2023) · Cancers · doi:10.3390/cancers15235652 · Cited by 22
Cho, K. R., Lee, M. H., Kong, D., Seol, H. J., Nam, D., Sun, J., Ahn, J. S., Ahn, M., Park, K., Kim, S. T., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1915-x · Cited by 22
Linot, B., Campone, M., Augereau, P., Delva, R., Abadie‐Lacourtoisie, S., Nebout-Mesgouez, N., & Capitain, O. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1378-5 · Cited by 22
Significance of histology in determining management of lesions regrowing after radiosurgery
Nath, S. K., Sheridan, A. D., Rauch, P. J., Yu, J. B., Minja, F. J., Vortmeyer, A. O., & Chiang, V. (2014) · Journal of Neuro-Oncology · doi:10.1007/s11060-014-1389-2 · Cited by 22
Self-citationMatikas, A., Kentepozidis, N. K., Georgoulias, V., & Kotsakis, A. P. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.05.006 · Cited by 24
Engelhardt, E. G., Révész, D., Tamminga, H. J., Punt, C. J. A., Koopman, M., Onwuteaka-Philipsen, B. D., Steyerberg, E. W., Jansma, I. P., de Vet, H. C. W., & Coupé, V. M. H. (2017) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2017.06.007 · Cited by 22
Gamma Knife Radiosurgery for the Management of More Than 15 Cerebral Metastases
Bowden, G. N., Faramand, A. M., Niranjan, A., Lunsford, L. D., & Monaco, E. A. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.03.019 · Cited by 22
Gutierrez-Valencia, E., Sanchez-Rodriguez, I. E., Ricardo, B.-I., Jesus, F.-L., Alan, R.-M., Inigo, V. A. A., Luis, B.-L., Allan, H. C., Puebla‐Mora, A. G., Liliana, N.-R., et al. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2019.20 · Cited by 23
Wang, W., Sun, X. S., & Hui, Z. (2019) · Oncology Research and Treatment · doi:10.1159/000502755 · Cited by 22
Arrieta, O. G., Ramírez‐Tirado, L., Caballé‐Perez, E., Mejia‐Perez, A., Zatarain-Barrón, Z. L., Cardona, A. F., Lozano-Ruiz, F. J., Segura‐González, M., Cruz‐Rico, G., Maldonado, F., et al. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13359 · Cited by 22
Filho, A. L. M. G., Conklin, J., Longo, M. G. F., Cauley, S., Polak, D., Liu, W., Splitthoff, D. N., Lo, W., KIRSCH, J. E., Setsompop, K., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.587327 · Cited by 22
Wang, M., Wu, Q., Zhang, J., Qin, G., Yang, T., Liu, Y., Wang, X., Zhang, B., & Wei, Y. (2020) · Cancer Medicine · doi:10.1002/cam4.3562 · Cited by 22
Central Nervous System Metastases
Nieblas‐Bedolla, E., Zuccato, J., Kluger, H. M., Zadeh, G. M., & Brastianos, P. K. (2021) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2021.08.004 · Cited by 22
Minniti, G. C., Lanzetta, G., Capone, L., Giraffa, M., Russo, I., Cicone, F., Bozzao, A., Alongi, F., Nicosia, L., Fineschi, G., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003730 · Cited by 22
Palliative Radiotherapy: Current Status and Future Directions
Sharma, S., Hertan, L. M., & Jones, J. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.09.021 · Cited by 22
Menoux, I., Armspach, J., Noël, G., & Antoni, D. (2016) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2016.07.098 · Cited by 21
McGranahan, T. M., & Nagpal, S. (2017) · Current Treatment Options in Oncology · doi:10.1007/s11864-017-0466-0 · Cited by 21
Stereotactic radiosurgery and local control of brain metastases from triple-negative breast cancer
Kowalchuk, R. O., Niranjan, A., Hess, J. A., Antonios, J. P., Zhang, M. Y., Braunstein, S. E., Ross, R. B., Pikis, S., Deibert, C. P., Lee, C.-C., et al. (2022) · Journal of neurosurgery · doi:10.3171/2022.10.jns221900 · Cited by 21
Self-citationLiao, C.-Y., Lee, C., Yang, H., Chen, C., Chung, W., Wu, H., Guo, W., Liu, R.-S., & Lu, C. (2023) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-023-01234-7 · Cited by 21
Integrating Artificial Intelligence and Machine Learning Into Cancer Clinical Trials
Kang, J., Chowdhry, A. K., Pugh, S. L., & Park, J. H. (2023) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2023.06.004 · Cited by 21
Brem, S. S., Meyers, C. A., Palmer, G., Booth‐Jones, M., Jain, S., & Ewend, M. G. (2013) · Cancer · doi:10.1002/cncr.28307 · Cited by 21
Nervous System Metastases From Systemic Cancer
Lee, E. Q. (2015) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000464178.81957.18 · Cited by 21
Preusser, M., Berghoff, A. S., Schadendorf, D., Lin, N., & Stupp, R. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328359320d · Cited by 21
Self-citationFontanella, C., Carlo, E. D., Cinausero, M., Pelizzari, G., Venuti, I., & Puglisi, F. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.03.014 · Cited by 21
Raco, A., Pesce, A., Fraschetti, F., Frati, A., D’Andrea, G., Cimatti, M., & Acqui, M. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.04.063 · Cited by 21
Saraf, A., Grubb, C. S., Hwang, M. E., Tai, C.-H., Wu, C., Jani, A., Lapa, M. E., Andrews, J. I. S., Vanderkelen, S., Isaacson, S. R., et al. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-017-2549-y · Cited by 21
The Current Role of Whole Brain Radiation Therapy in Non–Small Cell Lung Cancer Patients
Loganadane, G., Hendriks, L. E. L., Pechoux, C. L., & Lévy, A. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.07.006 · Cited by 21
Chen, K., Yu, X., Zhang, F., Xu, Y., Zhang, P., Huang, Z., & Fan, Y. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.08.023 · Cited by 21
Renz, P. B., Hasan, S., & Wegner, R. E. (2019) · Journal of Geriatric Oncology · doi:10.1016/j.jgo.2019.01.017 · Cited by 21
Mizuno, T., Takada, K., Hasegawa, T., Yoshida, T., Murotani, K., Kobayashi, H., Sakurai, T., Yamashita, Y., Akazawa, N., & Kojima, E. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1830 · Cited by 23
Tripathy, D., Tolaney, S. M., Seidman, A. D., Anders, C. K., Ibrahim, N. K., Rugo, H. S., Twelves, C. J., Dieras, V. C., Müller, V., Tagliaferri, M. A., et al. (2019) · Future Oncology · doi:10.2217/fon-2019-0180 · Cited by 21
Quality-of-life trajectories after stereotactic radiosurgery for brain metastases
Bunevičius, A., Lavezzo, K., Shabo, L. M., McClure, J. J., & Sheehan, J. P. (2020) · Journal of neurosurgery · doi:10.3171/2020.4.jns20788 · Cited by 21
Role of radiation therapy in brain metastases management
Dhermain, F. G., Noël, G., Antoni, D., & Tallet, A. R. (2020) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2020.06.013 · Cited by 22
Novel Treatment Strategies for Brain Metastases in Non-small-cell Lung Cancer
Bui, N. Q., Woodward, B. D., Johnson, A., & Husain, H. (2016) · Current Treatment Options in Oncology · doi:10.1007/s11864-016-0400-x · Cited by 21
Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy.
Hall, K. E., & Ramirez, R. A. (2017) · PubMed Central · Cited by 21
Protopapa, M., Kouloulias, V., Nikoloudi, S., PAPADIMITRIOU, C. A., Gogalis, G., & Zygogianni, A. G. (2019) · Journal of Oncology · doi:10.1155/2019/3267409 · Cited by 21
Lu, Y., & Fan, Y. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95871 · Cited by 20
Gilbride, L., Siker, M., Bovi, J. A., Gore, E., Schultz, C. J., & Hall, W. A. (2018) · Neurosurgery · doi:10.1093/neuros/nyx631 · Cited by 20
Chen, Y., Chen, Y., Chen, C., Shih, J., & Yu, C. (2019) · BMC Cancer · doi:10.1186/s12885-019-6140-0 · Cited by 20
The Clinical Frailty Scale as useful tool in patients with brain metastases
Kerschbaumer, J., Krigers, A., Demetz, M., Pinggera, D., Klingenschmid, J., Pichler, N., Thomé, C., & Freyschlag, C. F. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-04008-5 · Cited by 20
Analysis of prognostic factors in patients with brain metastases affecting survival
Gupta, S., Singh, S. K., Chophy, A., Nair, S., Ahuja, R., Kusum, K., Joseph, D. M., Arora, R. K., Gupta, A., & Gupta, M. (2022) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-022-00146-z · Cited by 20
Metadata
- Authors
- Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
- Affiliations
- University of Minnesota (US)
- University of California, San Francisco (US)
- McGill University (CA)
- Cleveland Clinic (US)
- Author affiliations appear at the end of this article.
- Mayo Clinic (US)
- Harvard University (US)
- Duke University (US)
- University of Colorado Denver (US)
- University of Alabama at Birmingham (US)
- Yale University (US)
- Hofstra University (US)
- Dartmouth College (US)
- Northwestern University (US)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2012-02-01
- Volume
- 30
- Issue
- 4
- Pages
- 419-425
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- PMC
- PMC3269967
- OpenAlex
- W1974820090
- Cited by
- 1,425
- References
- 21
- Citations by year
- 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
- FWCI
- 45.80
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P30CA-77598, P30CA077598)
- Topics
- Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
- Health Sciences › Medicine › Surgery › Management of metastatic bone disease
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
- MeSH terms
- Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review